Clinical Trial Update: CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial of oxaliplatin, capecitabine, and sorafenib in advanced pancreatic and biliary carcinomas completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bile Duct Neoplasms
• Pancreatic Neoplasms

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)
• Sorafenib (Sorafenib)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Pancreatic Neoplasms, Bile Duct Neoplasms | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-08-08